• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthabortion

Mark Cuban’s online pharmacy is offering steep discounts on birth control and Plan B–like drugs as people stock up after Roe is overruled

By
Andrew Marquardt
Andrew Marquardt
Down Arrow Button Icon
By
Andrew Marquardt
Andrew Marquardt
Down Arrow Button Icon
June 27, 2022, 2:06 PM ET
Portrait of Mark Cuban
Mark Cuban’s Cost Plus Drug Company is offering birth control and Plan B equivalents for as little as $6.09 in the aftermath of Roe v. Wade being overturned.Christopher Willard—Getty Images

Mark Cuban’s low-cost drug company is offering an affordable solution to those looking for birth control pills or emergency contraceptives in the aftermath of the Supreme Court overturning the right to an abortion last week. 

Cuban’s Cost Plus Drug Company, which offers a wide range of generic drugs priced at a 15% markup of manufacturing costs, plus a $3 pharmacy handling fee and a $5 shipping fee, sells 14 different birth control and emergency contraceptives on its site.

The company also offers two different versions of pills, levonorgestrel and ethinyl estradiol, and levonorgestrel and ethinyl estradiol–ethinyl estradiol, that contain levonorgestrel, which is the main ingredient used in Plan B and other emergency contraceptive pills, and significantly decrease the chance of pregnancy when taken within 72 hours of unprotected sex. Planned Parenthood lists these drugs as oral contraceptive pills that can also be used as emergency contraception. 

Levonorgestrel and ethinyl estradiol—the generic name for birth control pill Levora—is available for $6.09 on Cuban’s site, more than $35 less than retail prices, according to Cost Plus Drug Co.’s website. Levonorgestrel and ethinyl estradiol–ethinyl estradiol—the generic name for Daysee—is sold at Cost Plus for $9.04, a whopping $200 less than retail prices, according to the company’s website. 

Cost Plus Drug Company, which launched in January, does not currently accept insurance, but it claims its prices are still below what patients would pay with insurance at a typical pharmacy.

In the days following the Supreme Court’s decision to overturn Roe v. Wade, the 50-year-old court ruling that established access to an abortion a constitutional right, sales of emergency contraceptive pills have surged across the country.

Stix, a reproductive health company, told the New York Times that sales of its morning-after pill Restart surged more than 600% in the 24 hours after the Supreme Court decision was released. Similarly, health care products site Wellspring Meds told the outlet that it sold 6,000 units of emergency contraception pills the same day Roe v. Wade was overturned, up from 1,000 units the day before.  

Since Friday, when the Supreme Court decision was made official, Cuban has retweeted several tweets confirming the company’s commitment to selling affordable birth control and emergency contraceptives in the wake of Roe being overturned. 

“Been looking for some effective ways to help spread info on finding birth control, @mcuban started his own pharmaceutical company called @costplusdrugs, I looked and they have a morning after pills in stock,” wrote one user in a tweet that Cuban later retweeted.

https://twitter.com/DJJHEAT973/status/1540503598597111808

“PSA: @mcuban’s new online pharmacy is selling birth control and other life-saving meds at extreme discounts. Stock up now. Spread the word,” wrote another user in a separate tweet also later retweeted by Cuban.

PSA: @mcuban’s new online pharmacy is selling birth control and other life-saving meds at extreme discounts. Stock up now. Spread the word. https://t.co/635TGElH8Q

— Eliza Orlins (@elizaorlins) June 24, 2022

The company has pledged not to spend any money on marketing, relying entirely instead on word of mouth. Doing so “allows us to price at such low prices,” Cuban said on Twitter. 

Last week, a study revealed that Medicare’s drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing strategy of Cost Plus Drug Company. Cuban and his online pharmacy had zero involvement in the study, according to its researchers. 

After the study was published, Cuban tweeted it out with a message to President Biden and members of Congress: “Have your people call my people and let’s get this done.”

Neither Cuban nor Cost Plus Drug Co. immediately responded to Fortune’s request for comment.

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Andrew Marquardt
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Best Outdoor Saunas
Healthoutdoor and sporting goods
The Best Outdoor Saunas of 2026: Tested and Reviewed
By Christina SnyderJanuary 14, 2026
19 hours ago
Healthchief executive officer (CEO)
Elon Musk says humans are ‘pre-programmed to die’ and longevity is ‘solvable’, raising huge questions about the future of health
By Marco Quiroz-GutierrezJanuary 14, 2026
23 hours ago
hybrid
Future of Workhybrid
‘Hybrid creep’ is the latest trick bosses are using to get workers back in the office
By Nick LichtenbergJanuary 13, 2026
2 days ago
Successthe future of work
Elon Musk shares 4 bold predictions for the future of work: Robot surgeons in 3 years, immortality, and no need for retirement savings
By Orianna Rosa RoyleJanuary 13, 2026
2 days ago
Healthexercise
5 daily tasks that can double as exercise
By Molly Liebergall and Morning BrewJanuary 12, 2026
2 days ago
A smartphone displaying the app icon for Anthropic AI chatbot Claude displayed against a backdrop that also says "Claude."
AIAnthropic
Anthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records
By Jeremy KahnJanuary 11, 2026
3 days ago

Most Popular

placeholder alt text
Personal Finance
Peter Thiel makes his biggest donation in years to help defeat California’s billionaire wealth tax
By Nick LichtenbergJanuary 14, 2026
15 hours ago
placeholder alt text
Success
Despite his $2.6 billion net worth, MrBeast says he’s having to borrow cash and doesn’t even have enough money in his bank account to buy McDonald’s
By Emma BurleighJanuary 13, 2026
2 days ago
placeholder alt text
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the capitalist system'
By Jason MaJanuary 12, 2026
3 days ago
placeholder alt text
AI
Being mean to ChatGPT can boost its accuracy, but scientists warn you may regret it
By Marco Quiroz-GutierrezJanuary 13, 2026
2 days ago
placeholder alt text
Future of Work
'Microshifting,' an extreme form of hybrid working that breaks work into short, non-continuous blocks, is on the rise
By Nick LichtenbergJanuary 13, 2026
2 days ago
placeholder alt text
Economy
Goldman Sachs top economist says Powell probe won’t change the Fed: 'Decisions are going to be made based on employment and inflation'
By Sasha RogelbergJanuary 12, 2026
3 days ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.